In an elderly male patient receiving amlodipine, a beta‑blocker, and lisinopril who has been started on a rifampin‑containing first‑line anti‑tuberculosis regimen, which antihypertensive medication should be discontinued?

Amlodipine Should Be Stopped

In an elderly male on amlodipine, a beta-blocker, and lisinopril who is started on rifampin-containing first-line anti-TB therapy, amlodipine should be discontinued or significantly dose-reduced due to severe drug-drug interactions with rifampin that will render it ineffective.

Mechanism of Interaction

Rifampin is a potent inducer of hepatic cytochrome P450 enzymes (particularly CYP3A4), which dramatically reduces the bioavailability and therapeutic effect of calcium channel blockers like amlodipine 1. This interaction is well-documented:

• Amlodipine exposure decreases by >50% when co-administered with rifampin, with drug levels becoming undetectable in 50-75% of patients 2
• Studies show rifampin reduces amlodipine AUC by approximately 96%, essentially eliminating its antihypertensive effect 3
• This leads to worsening hypertension in 100% of patients, with 83% requiring increased antihypertensive medications and 46% experiencing hypertensive crises 2, 4

Why Not the Other Medications?

Beta-blockers: While rifampin can induce metabolism of some beta-blockers (particularly metoprolol), the interaction is less severe than with calcium channel blockers. Beta-blockers metabolized via alternative pathways or with renal elimination (like atenolol) can be used with dose adjustment 5, 1.

Lisinopril (ACE inhibitor): This is the safest choice to continue. ACE inhibitors are not metabolized by cytochrome P450 enzymes and have no clinically significant interaction with rifampin 6. Lisinopril is primarily renally eliminated and its pharmacokinetics are unaffected by rifampin 7.

Clinical Management Algorithm

1. Immediately discontinue amlodipine when rifampin is initiated
2. Maintain lisinopril at current dose (no adjustment needed)
3. Continue beta-blocker with close monitoring; may require dose increase
4. Add alternative antihypertensives if needed:
   • Consider increasing ACE inhibitor dose
   • Add thiazide diuretic (minimal rifampin interaction)
   • Avoid other calcium channel blockers (same interaction problem)

Critical Monitoring Points

• Blood pressure should be monitored every 2-3 days for the first 2 weeks after rifampin initiation 2
• Mean time to first hypertensive crisis is 9 days after rifampin start 2
• Hypertensive emergencies (including acute pulmonary edema) occurred in patients who continued calcium channel blockers with rifampin 2
• The interaction persists for at least 2 weeks after rifampin discontinuation due to ongoing enzyme induction 5, 1

Additional Considerations for This Elderly Patient

Given the patient's age and triple antihypertensive therapy, he likely has:

• Established cardiovascular disease or high risk
• Possible renal impairment (common in elderly on ACE inhibitors)

Hepatotoxicity monitoring is essential as rifampin, isoniazid, and pyrazinamide can all cause liver injury 7, 8, 7. Baseline and serial liver function tests (ALT, AST, bilirubin) should be performed, especially given the concurrent use of multiple medications 1, 9.

The combination of rifampin with ACE inhibitors and beta-blockers is pharmacologically sound and supported by guidelines, whereas continuing amlodipine would result in therapeutic failure and potentially dangerous blood pressure elevation 2, 4, 10.